Nutraceuticals and Functional Foods: The Foods for the Future World

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 16, 2016, Pages 2617-2627

  Gul, Khalid ^a   Singh, A K ^a   Jabeen, Rifat ^b  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

^b ISLAMIC UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

cancer; functional foods; health benefits; Nutraceuticals

Indexed keywords

ANIMALS; DISEASES; HEALTH; KNOWLEDGE BASED SYSTEMS;

CANCER; CARDIO-VASCULAR DISEASE; FRUITS AND VEGETABLES; FUNCTIONAL ATTRIBUTE; GASTROINTESTINAL TRACT; HEALTH BENEFITS; NUTRACEUTICALS; SCIENTIFIC KNOWLEDGE BASE;

FUNCTIONAL FOOD;

ANIMAL; CARDIOVASCULAR DISEASE; DAIRY PRODUCT; DIETARY SUPPLEMENT; EDIBLE PLANT; FISH; FRUIT; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASE; HEALTH PROMOTION; HUMAN; NEOPLASM; NOMENCLATURE; OBESITY; SEA FOOD; VEGETABLE; WINE;

ANIMALS; CARDIOVASCULAR DISEASES; DAIRY PRODUCTS; DIETARY SUPPLEMENTS; FISHES; FRUIT; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASES; HEALTH PROMOTION; HUMANS; NEOPLASMS; OBESITY; PLANTS, EDIBLE; SEAFOOD; TERMINOLOGY AS TOPIC; VEGETABLES; WINE;

EID: 84983034017     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2014.903384     Document Type: Review

References (131)

1. H.Adlercreutz, T.Fotsis, R.Heikkinen, J.T.Dwyer, M.Woods, B.R.Goldin, and S.L.Gorbach, (1982). Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. The Lancet. 320:1295–1299.
2. Agriculture and Agri-Food Canada. (2009). What are functional foods and nutraceuticals? Available from www4.agr.gc.ca. Accessed Nov13, 2013.
3. E.E.Alvarez-Leon, B.Roman-Vinas, and L.Serra-majem, (2006). Dairy products and health:A review of the epidemiological evidence. Br. J. Nutr. 96:94–99.
4. M.A.Allman, M.M.Pena, and D.Pang, (1995). Supplementation with flax seed oil versus sunflower seed oil in healthy young men consuming a low fat diet:Effects on platelet composition and function. Eur. J. Clin. Nutr. 49:169–178.
5. H.Amagase, B.Petesch, H.Matsuura, S.Kasuga, and Y.Itakara, (2001). Impact of various sources of garlic and their constituents on 7,12-dimethlybenz(a)anthracene binding to mammary cell DNA. Carcinogenesis (Lond). 14:1427–1631.
6. American Dietetic Association (ADA). (1995). Position of the American Dietetic Association:Phytochemicals and functional foods. J. Am. Diet. Assoc. 95:493–496.
7. American Dietetic Assocaition (ADA). (1999). Functional foods-position of the ADA. J. Am. Diet. Assoc. 99:1278–1285.
8. American Health Foundation (AHF). (1992). Physiological and pharmacological effects of Camellia sinensis (tea):Implications for cardiovascular disease, cancer, and public health. American Health Foundation, Valhalla, New York. Prevent. Med. 21:329–391 and 503–553.
9. J.J.Anderson, W.W.Ambrose, and S.C.Garner, (1995a). Orally dosed genistein from soy and prevention of cancellous bone lossin two ovariectomized rat models. Abstract. J. Nutr. 125:799.
10. J.J.B.Anderson, and S.C.Garner, (1997). The effects of phytoestrogens on bone. Nutr. Res. 17:1617–1632.
11. J.W.Anderson, B.M.Johnstone, and M.E.Cook-Newell, (1995b). Meta- analysis of the effects of soy protein in-take on serum lipids. New Engl. J. Med. 333:276–282.
12. A.Ascherio, E.B.Rimm, M.J.Stampfer, E.L.Giovannucci, and W.C.Willett, (1995). Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. New Eng. J. Med. 332:977–982.
13. I.Awasom, (2011). Tea. J. Agric. Food Inf. 12:12–22.
14. C.Balsano, and A.Alisi, (2009). Antioxidant effects of natural bioactive compounds. Curr. Pharm. Des. 15:3036–3073.
15. J.O.Ban, D.Y.Yuk, K.S.Woo, T.M.Kim, U.S.Lee, H.S.Jeong, D.J.Kim, Y.B.Chung, B.Y.Hwang, K.W.Oh, and J.T.Hong, (2007). Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulphur compound isolated from garlic in human colon cancer cells. J. Pharmacol. Sci. 104:374–383.
16. H.O.Bang, and J.Dyerberg, (1972). Plasma lipids and lipoproteins in Greenlandic west-coast Eskimos. Acta. Med. Scand. 192:85–94.
17. M.L.Bierenbaum, R.Reichstein, and T.R.Watkins, (1993). Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation:A preliminary report. J. Am. Coll. Nutr. 12:501–504.
18. E.Block, (1992). The organosulfur chemistry of the genus Allium – Implications for the organic chemistry of sulfur. Angew. Chem. Int. Edn. Engl. 31:1135–1178.
19. G.Block, B.Patterson, and A.Subar, (1992). Fruit, vegetables, and cancer prevention:A review of the epidemiological evidence. Nutr. Cancer. 18:1–29.
20. C.Borek, (2006). Garlic reduces dementia and heart-disease risk. J. Nutr. 136:810S–812S.
21. S.J.Bowlin, M.C.Leske, A.Varma, P.Nasca, A.Weinstein, and L.Caplan, (1997). Breast cancer risk and alcohol consumption:Results from a large case-control study. Int. J. Epidemiol. 26:915–923.
22. M.S.Butt, M.T.Nadeem, M.K.I.Khan, R.Shabir, and M.S.Butt, (2008). Oats:Unique among the cereals. Eur. J. Nutr. 47:68–79.
23. M.S.Butt, M.T.Sultan, M.S.Butt, and J.Iqbal, (2009). Garlic:Nature's protection against physiological threats. Crit. Rev. Food Sci. Nutr. 49:538–551.
24. M.C.Casiraghi, M.Garsetti, G.Testolin, and F.Brighenti, (2006). Post-prandial responses to cereal products enriched with barley glucan. J. Am. Coll. Nutr. 25:313–320.
25. A.Cencic, and W.Chingwaru, (2010a). Antimicrobial agents deriving from indigenous plants. RPFNA. 2:83–92.
26. A.Cencic, and W.Chingwaru, (2010b). The role of functional foods, nutraceuticals and food supplements in intestinal health. Nutrients. 2:611–625.
27. N.Chaturvedi, P.Sharma, K.Shukla, R.Singh, and S.Yadav, (2007). Cereals nutraceuticals, health ennoblement and disease obviation:A comprehensive review. J. Appl. Pharm. Sci. 1:6–12.
28. M.Choudhary, and K.Grover, (2012). Development of functional food products in relation to obesity. Funct. Foods Health Dis. 2:188–197.
29. L.Chen, G.E.Remondetto and M.Subirade, (2006). Food protein-based materials as nutraceutical delivery systems. Trends Food Sci. Technol. 17:272–283.
30. Y.F.Chu, M.L.Wise, A.A.Gulvady, T.Chang, D.F.Kendra, et al (2013). In vitro antioxidant capacity and anti-inflammatory activity of seven common oats. Food Chem. 139:426–431.
31. F.M.Clydesdale, (1997). A proposal for the establishment of scientific criteria for health claims for functional foods. Nutr. Rev. 55(12):413–422.
32. S.C.Cunnane, S.Ganguli, C.Menard, A.C.Liede, M.J.Hamadeh, Z.Y.Chen, T.M.S.Wolever, and D.J.A.Jenkins, (1993). High-linolenic acid flaxseed (Linum usitatissimum):Some nutritional properties in humans. Br. J. Nutr. 69:443–453.
33. A.Denny, and J.Buttriss, (2005). Plant foods and health:Focus on plant bioactives, British Nutrition Foundation. Synthesis Report No. 4. Available from www.eurofir.net/temp/PLANTspFOODSspANDspHEALTHspFOCUSspONspBIOACTIVEShs1hs.pdf. Assessed November15, 2013.
34. Department of Health and Human Services/Food and Drug Administration. DHHS/FDA. (1997). Food labeling:Health claims; oats and coronary heart disease. Fed. Reg. 62:3584–3601.
35. E.Dorant, P.A.van den Brandt, R.A.Goldbohm, R.J.J.Hermus, and F.Sturmans, (1993). Garlic and its significance for the prevention of cancer in humans:A critical review. Br. J. Cancer. 67:424–429.
36. J.Dwyer, (1995). Overview:Dietary approaches for reducing cardiovascular disease risks. J. Nutr. 125:656–665.
37. European Food Safety Authority (EFSA). (2004). Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. The EFSA J. 81:1–49.
38. J.W.Erdman, and S.M.Potter, (1997). Soy and bone health. The Soy Connect. 5(2):1–4.
39. E.Ernst, (1997). Can allium vegetables prevent cancer? Phytomedicine. 4:79–83.
40. J.C.Espin, M.T.Garcia-Conesa, and F.A.Tomas-Barberan, (2007). Nutraceuticals:Facts and fiction. Phytochemistry. 68:2986–3008.
41. Food and Agricultural Organization of the United Nations (FAO). (2007). Report on Functional Foods. Available from www.fao.org. Accessed on November14, 2013.
42. Food and Drug Administration (FDA). (1997). Final rule:Food labeling:Health claims. Oats and coronary heart diseases. In:Federal Register, Vol. 62, No. 231, pp. 3584–3681. FDA, Washington, DC.
43. Food and Drug Administration (FDA). (2005). Health claims:Soluble fibre from certain foods and coronary heart diseases (CHD). In:Federal Register, Vol. 70, pp. 76150–76162. FDA, Washington, DC.
44. E.N.Frankel, J.Kanner, J.B.German, E.Parks, and J.E.Kinsella, (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. The Lancet. 341:454–457.
45. R.Fuller, (1994). History and development of probiotics. In:Probiotics, pp. 1–8. R.Fuller, Ed., Chapman & Hall, New York, NY.
46. J.S.Godber, and J.H.Well, (1994). Rice bran:as a viable source of high value chemicals, Louisiana Agric. 37 (2):13–17.
47. H.N.Graham, (1992). Green tea composition, consumption and polyphenol chemistry. Prev. Med. 21:334–350
48. M.E.Harbowy, and D.A.Balentine, (1997). Tea chemistry. Crit. Rev. Plant Sci. 16:415–480.
49. W.S.Harris, (1996). N-3 fatty acids and lipoproteins. Comparison of results from human and animal studies. Lipids. 31:243–252.
50. D.W.Haslam, and W.P.James, (2005). Obesity. The Lancet. 366:1197–1209.
51. C.M.Hastler, S.Kundrat, and D.Wool, (2000). Functional foods and cardiovascular disease. Curr. Atheroscler. Rep. 2:467–475.
52. K.Hayat, H.Iqbal, U.Malik, U.Bilal, and S.Mushtaq, (2013). Tea and its consumption:Benefits and risks. Crit. Rev. Food Sci. Nutr. 55(7):939–954. doi:http://dx.doi.org/10.1080/10408398.2012.678949.
53. M.G.L.Hertog, E.J.M.Feskens, P.C.H.Hollman, M.B.Katan, and D.Krumhout, (1993). Dietary antioxidant flavonoids and risk of coronary heart disease:The Zutphen Elderly Study. The Lancet. 342:1007–1011.
54. J.M.Hodgson, I.B.Puddey, L.J.Beilin, T.A.Mori, and K.D.Croft, (1998). Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations:A randomized controlled trial in humans. J. Nutr. 128:728–732.
55. B.V.Howard, and D.Kritchevsky, (1997). Phytochemicals and cardiovascular disease – A statement for healthcare professionals from the American Heart Association. Circulation. 95:2591–2593.
56. ILSI. (2008). International Life Science Institute, Washington, DC. Retrieved from http://www.ilsi.org/Europe/Publications/C2008Func_FoodEng.pdf.
57. International Obesity Task Force (IOTF). (2005).Obesity in Europe, EU Platform Briefing Paper, prepared by Lobstein, T. and Rigby, N. in collaboration with European Association for the Study of Obesity. Available from www.iaso.org/popout.asp?linkto=http%3A//www.iotf.org/media/euobesity3.pdf. Accessed November13, 2013.
58. S.Kalimuthu, and K.Se-Kwon, (2013). Cell survival and apoptosis signalling as therapeutic target for cancer:Marine bioactive compounds. Int. J. Mol. Sci. 14:2334–2354.
59. N.Kalra, A.Arora, and Y.Shukla, (2006). Involvement of multiple signalling pathways in diallyl sulphide mediated apoptosis in mouse skin tumours. Asian. Pac. J. Cancer Prev. 7:556–562.
60. J.Kanner, E.Frankel, R.Granit, B.German, and J.E.Kinsella, (1994). Natural antioxidants in grapes and wines. J. Agric. Food Chem. 42:64–69.
61. S.K.Katiyar, and H.Mukhtar, (1996). Tea in chemoprevention of cancer:Epidemiologic and experimental studies (review). Intl. J. Oncol. 8:221–238.
62. J.Khatiwada, M.Verghese, L.T.Walker, L.Shackelford, C.B.Chawan, and R.Sunkara, (2006). Combination of green tea, phytic acid, and inositol reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. LWT Food Sci. Tech. 39:1080–1086.
63. Y.A.Kim, D.Xiao, H.Xiao, A.A.Powolmy, K.L.Lew, M.L.Reilly, Y.Zeng, Z.Wang, and S.V.Singh, (2007). Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol. Cancer Ther. 6:1599–1609.
64. L.Kohlmeier, K.G.C.Weerings, S.Steck, and F.J.Kok, (1997). Tea and cancer prevention – An evaluation of the epidemiologic literature. Nutr. Cancer. 27:1–13.
65. J.Kojuri, A.R.Vosoughi, and M.Akrami, (2007). Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis. 1:6:5.
66. D.Krumhout, E.B.Bosschieter, and C.de Lezenne Coulander, (1985). The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New Eng. J. Med. 312:1205–1209.
67. G.Kuttan, (2000). Immunomodulatory effect of some maturally occurring sulphur-containing compounds. J Ethnopharmacol. 72:93–99.
68. J.W.Lampe, (1999). Health effects of vegetables and fruit:Assessing mechanisms of action in human experimental studies. Am. J. Clin. Nutr. 70:475–490.
69. L.D.Lawson, Z.Y.J.Wang, and B.G.Hughes, (1991). Identification and HPLC quantitation of the sulfides and dialk(en)ylthiosulfinates in commercial garlic products. Planta Med. 57:363–370.
70. R.H.Liu, (2003). Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 78:517–520.
71. R.H.Liu, (2004). Potential synergy of phytochemicals in cancer prevention:Mechanism of action. J. Nutr. 134:3479–3485.
72. M.Mahmoodi, M.R.Islami, G.R.Asadi-Karam, M.Khaksari, A.SahebghadamLotfi, M.R.Hajizadeh, and M.R.Mirzaee, (2006). Study of the effects of raw garlic consumption on the level of lipids and other blood biochemical factors in hyperlipidemic individuals. Pak. J. Pharm. Sci. 19:295–298.
73. Y.Malkki, and E.Virtanen, (2001). Gastrointestinal effects of oat bran and oat gum:A review. LWT Food Sci Technol. 34:337–347.
74. R.Martorell, L.Kettel Khan, M.L.Hughes, and L.M.Grummer-Strawn, (2000). Overweight and obesity in preschool children from developing countries. Int. J. Obes. Relat. Metab. Disord. 24:959–967.
75. N.Matsura, Y.Miryamae, K.Yamane, Y.Nagao, Y.Hamada, N.Kawaguchi, T.Katsuki, K.Hirata, S.Surmi, and H.Ishikawa, (2006). Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J. Nutr. 136:842–846.
76. G.Mazza, (1998). Functional Food, Biochemical and Processing Aspects. Technomic, Lancaster, PA., 437 pp.
77. E.Metchnikoff, (1907). The Prolongation of Life. William Heinemann, London.
78. D.Meyer, and M.Stasse-Wolthuis, (2009). The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur. J. Clin. Nutr. 63:1277–1289.
79. B.K.Mital, and S.K.Garg, (1995). Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus. Crit. Rev. Micro. 21:175–214.
80. R.A.Nagourney, (1998). Garlic:Medicinal food or nutritious medicine? J. Med. Food. 1:13–28.
81. K.Nakachi, K.Suemasu, K.Suga, T.Takeo, K.Imai, and Y.Higashi, (1998). Influence of drinking green tea on breast cancer malignancy among Japanese. Jpn. J. Cancer Res. 89:254–261.
82. P.J.Nestle, T.Yamashita, T.Sasahara, S.Pomeroy, A.Dart, P.Komesaroff, A.Owen, and M.Abbey, (1997). Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17:3392–3398.
83. T.O.Obisesan, R.Hirsch, O.Kosoko, L.Carlson, and M.Parrott, (1998). Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J. Am. Geriatr. Soc. 46:1–7.
84. B.D.Oomah, (2001). Flaxseed as a functional food source. J. Sci. Food Agric. 81:889–894.
85. M.Daviglus, J.Sheeshka, and E.Murkin, (2010). Health benefits from eating fish. Comments Toxicol. 8:345–374.
86. M.H.Pan, G.Ghai, and C.T.Ho, (2008). Food bioactives, apoptosis, and cancer. Mol. Nutr. Food Res. 52:43–52.
87. M.A.Pereira, and D.S.Ludwig, (2001). Dietary fibre and body weight regulation:Observations and mechanisms. Ped. Clin. N. Am. 48:969–980.
88. J.M.Pezzuto, (2008). Grapes and human health:A perspective. J. Agric. Food Chem. 56:6777–6784.
89. S.M.Potter, (1995). Overview of possible mechanisms for the hypercholesterolemic effect of soy protein. J. Nutr. 125:606–611.
90. S.M.Potter, (1998). Soy protein and cardiovascular disease:The impact of bioactive components in soy. Nutr. Rev. 56:231–235.
91. S.Rayalam, M.A.Della-Fera, and C.A.Baile, (2008). Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem. 19:717–726.
92. W.Renaud, and M.de Lorgeril, (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. The Lancet. 339:1523–1526.
93. H.D.Reuter, H.P.Koch, and L.D.Lawson, (1996). Therapeutic effects and applications of garlic and its preparations. In:Garlic. The Science and Therapeutic Application of Allium sativum L. and Related Species, 2nded. H.P.Koch, and L.D.Lawson, Eds., pp. 135–512. Williams & Wilkins, Baltimore, MD.
94. G.Riccioni, B.Mancini, E.Di Ilio, T.Bucciarelli, and N.D'Orazio, (2008). Protective effect of lycopene in cardiovascular disease. Eur. Rev. Med. Pharmacol. Sci. 12:183–190.
95. I.Rogelj, (2000). Milk, dairy products, nutrition and health. Food Technol. Biotechnol. 38(2):143–147.
96. M.E.Sanders, (1994). Lactic acid bacteria as promoters of human health. In:Functional Foods – Designer Foods, Pharmafoods, Nutraceuticals, pp. 294–322. I.Goldberg, Ed., Chapman & Hall, New York, NY.
97. Scientific Advisory Committee on Nutrition (SACN). (2004). Advice on fish consumption:Benefits and risks. Available from http://www.sacn.gov.uk/pdfs/fics_sacn_advice_fish.pdf. Assessed November23, 2013.
98. K.D.R.Setchell, A.M.Lawson, S.P.Borriello, R.Harkness, H.Gordon, D.M.L.Morgan, D.N.Kirk, H.Adlercreutz, L.C.Anderson, and M.Axelson, (1981). Lignan formation in man- microbial involvement and possible roles in relation to cancer. The Lancet. 318:4–7.
99. F.Shahidi, (2004). Functional foods:Their role in health promotion and disease prevention. J. Food Sci. 69:146–149.
100. F.Shahidi, (2009). Nutraceuticals and functional foods:Whole versus processed foods. Trends Food Sci. Technol. 20:376–387.
101. C.A.Silagy, and A.Neil, (1994a). Garlic as a lipid-lowering agent – a meta-analysis. J. Royal Coll. Physicians Lond. 28:39–45.
102. C.A.Silagy, and H.A.W.Neil, (1994b). A meta-analysis of the effect of garlic on blood pressure. J. Hyper. 12:463–468.
103. A.P.Simopoulos, (1991). Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54:438–463.
104. P.Singh, R.Kumar, S.N.Sabapathy, and A.S.Bawa, (2008). Functional and edible uses of soy protein products. Compr. Rev. Food Sci. Food Safety. 7:14–28.
105. B.B.Singh, S.P.Vinjamury, C.Der-Martirosian, E.Kubik, L.C.Mishra, N.P.Shepard, V.J.Singh, M.Meier, and S.G.Madhu, (2007). Ayurvedic and collateral herbal treatments for hyperlipidemia:A systematic review of randomized controlled trials and quasi-experimental designs. Alter. Ther. Health Med. 13:22–28.
106. K.C.Srivastava, A.Bordia, and S.K.Verma, (1995). Garlic (Allium sativum) for disease prevention. S. Afr. J. Sci. 91:68–77.
107. A.Steptoe, E.Gibson, R.Vuononvirta, M.Hamer, J.Wardle, J.Rycroft, J.Martin, and J.Erusalimsky, (2007). The effects of chronic tea intake on platelet activation and inflammation:A double-blind placebo controlled trial. Atherosclerosis. 193:277–282.
108. A.S.St. Leger, A.L.Cochrane, and F.Moore, (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. The Lancet. 313:1017–1020.
109. K.A.Steinmetz, and J.D.Potter, (1991b). Vegetables, fruit and cancer I. Cancer Causes Control. 2:325–357.
110. K.A.Steinmetz, H.Kushi, R.M.Bostick, A.R.Folsom, and J.D.Potter, (1994). Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am. J. Epidemiol. 139:1–15.
111. K.A.Steinmetz, and J.D.Potter, (1991a). Vegetables, fruit and cancer II. Mechanisms. Cancer Causes Control. 2:427–442.
112. M.Stramba-Badiale, K.M.Fox, S.G.Priori, P.Collins, C.Daly, I.Graham, B.Jonsson, B.Schenck, K.Gustafsson, and M.tendera, (2006). Cardiovascular diseases in women:A statement from the policy conference of the European Society of Cardiology. Eur. Heart J. 27:994–1005.
113. Y.J.Surh, (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 3:768–780.
114. R.Talamini, C.La Vecchia, A.Decarli, Franceschi, S., Grattoni, E., et al. (1984). Social factors, diet and breast cancer in a northern Italian population. Br. J. Cancer. 49:723–729.
115. P.Terry, E.Giovannucci, K.B.Michels, L.Bergkvist, H.Hansen, L.Holmberg, A.Wolk, (2001). Fruit, vegetables, dietary fiber and risk of colorectal cancer. J. Natl. Cancer. Inst. 93:525–533.
116. L.U.Thompson, (1995). Flaxseed, lignans, and cancer. In:Flaxseed in Human Nutrition, pp. 219–236. S.Cunnane, and L.U.Thompson, Eds., AOCS Press, Champaign, IL.
117. L.U.Thompson, P.Robb, M.Serraino, and F.Cheung, (1991). Mammalian lignan production from various foods. Nutr. Cancer. 16:43–52.
118. S.M.Tosh, Y.Brummer, T.M.S.Wolever, and P.Wood, (2008). Glycemic response to oat bran muffins treated to vary molecular weights of β-glucan. Cereal Chem. 85:211–217.
119. A.S.Truswell, (2002). Cereal grains and coronary heart diseases. Eur. J. Clin. Nutr. 56:1–14.
120. P.van't Veer, J.M.Dekker, J.W.J.Lamers, F.J.Kok, E.G.Schouten, H.A.M.Brants, F.Sturmans, and R.J.J.Hermus, (1989). Consumption of fermented milk products and breast cancer:A case-control study in the Netherlands. Cancer Res. 49:4020–4023.
121. C.Z.Wang, S.R.Mehendale, and C.S.Yuan, (2007). Commonly used antioxidant botanicals:Active constituents and their potential role on cardiovascular illness. Am. J. Chin. Med. 35:543–558.
122. A.A.Wani, P.Singh, M.A.Shah, U.S.Weisz, K.Gul, and I.A.Wani, (2012). Rice starch diversity:Effects on structural, morphological, thermal and physicochemical properties – A review. Compr Rev. Food Sci. Food Saf. 11:417–436.
123. S.Warshafsky, R.S.Kamer and S.L.Sivak, (1993). Effect of garlic on total serum cholesterol. A meta-analysis. Ann. Int. Med. 119:599–605.
124. J.H.Weisburger, (ed.). (1998). International symposium on lycopene and tomato products in disease prevention. Proc. Soc. Exp. Biol. Med. 218:93–143.
125. R.E.Wildman, (2001). Handbook of Nutraceuticals and Functional Foods. CRC Press, Boca Raton, FL.
126. G.Xu, G.Ren, X.Xu, H.Yuan, Z.Wang, L.Kang, W.Yu, and K.Tian, (2010). Combination of curcumin and green tea catechins prevents dimethylhydrazine- induced colon carcinogenisis. Food Chem. Toxicol. 48:390–395.
127. L.Yan, J.A.Yee, D.Li, M.H.McGuire, and L.U.Thompson, (1998). Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett. 124:181–186.
128. C.S.Yang, and Z.Y.Wang, (1993). Tea and cancer. J. Nat. Camcer Inst. 85:1038–1049.
129. W.-C.You, W.J.Blot, Y.-S.Chang, A.G.Ershow, Z.-T.Yang, Q.An, B.Henderson, G.W.Xu, J.F.Fraumeni, and T.G.Wang, (1988). Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 48:3518–3523.
130. S.H.Zeisel, (1999). Regulation of nutraceuticals. Science. 285:1853–1855.
131. Z.M.Zhang, X.Y.Yang, S.H.Deng, W.Xu, and H.Q.Gao, (2007). Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Chin. Med. J. (Engl). 120:1336–1342.